UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024521
Receipt number R000028225
Scientific Title Prospective, non-randomized, non-blinded clinical trial of granulocyte colony-stimulating factor for acute spinal cord injury
Date of disclosure of the study information 2016/10/21
Last modified on 2016/10/21 20:20:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective, non-randomized, non-blinded clinical trial of granulocyte colony-stimulating factor for acute spinal cord injury

Acronym

Clinical trial of G-CSF for spinal cord injury

Scientific Title

Prospective, non-randomized, non-blinded clinical trial of granulocyte colony-stimulating factor for acute spinal cord injury

Scientific Title:Acronym

Clinical trial of G-CSF for spinal cord injury

Region

Japan


Condition

Condition

spinal cord injury

Classification by specialty

Orthopedics Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the present trial is to elucidate the efficacy of granulocyte colony-stimulating factor for acute spinal cord inury.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Change of ASIA motor score between baseline and three months after G-CSF administration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Granulocyte colony-stimulating factor
10 microgam/kg/day, intravenous infusion for 5 days

Interventions/Control_2

conventional treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

acute spinal cord injury
Neurological level of injury between C4 and C7

Key exclusion criteria

1. allergy for G-CSF
2. Hematological malignancy
3. malignancy within 5 years
4. acute myocardial infarction
5. thorombosis
6. splenomegaly
7. consciousness disorder
8. pregnancy
9. neurological disorder which affects neurological evaluation

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhisa Takahashi

Organization

Chiba University Graduate School of Medicine

Division name

Department of Orthopedic Surgery

Zip code


Address

1-8-1 Inohana, Chuo-Ku, Chiba

TEL

043-226-2961

Email

chibaseikei8f@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masao Koda

Organization

Chiba University Graduate School of Medicine

Division name

Department of Orthopedic Surgery

Zip code


Address

1-8-1 Inohana, Chuo-Ku, Chiba

TEL

043-226-2961

Homepage URL


Email

chibaseikei8f@yahoo.co.jp


Sponsor or person

Institute

Ministry of Health, Labour and Welfare

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 10 Month 21 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 30 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 10 Month 21 Day

Last modified on

2016 Year 10 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028225


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name